GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...

New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer ...

Recent advancements in the study of cancer treatment are leading to fewer visits and side effects for patients receiving treatment through the Round Rock location of Baylor Scott & White Cancer Center ...

The radioactive drug industry is booming. The radiopharmaceuticals market is expected to grow 10% a year to reach more than ...

Researchers are testing CAR T-cell therapy as a treatment for lupus, Graves’ disease and other conditions in which the body’s ...

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say.

We also report on a potential new use for another approved medicine that helped ​reduce suicidal thoughts in patients with ...